Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids
Shaimaa M. Aboukhatwa, Peter A. Sidhom, Andrea Angeli, et al.
ACS Omega (2023) Vol. 8, Iss. 8, pp. 7666-7683
Open Access | Times Cited: 20

Showing 20 citing articles:

A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 33
Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights
Heba A. Elsebaie, Eman A. El-Bastawissy, Kamel M. Elberembally, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106799-106799
Closed Access | Times Cited: 23
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 15
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 15
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 8
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 22
Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study
Sanket Rathod, Sreenath Dey, Swaranjali Pawar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 10, pp. 5178-5196
Open Access | Times Cited: 18
Design, synthesis and cytotoxic activity of molecular hybrids based on quinolin-8-yloxy and cinnamide hybrids and their apoptosis inducing property
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Ola A. Abu Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11443-11451
Open Access | Times Cited: 5
Design and synthesis of quinazolin-4-one derivatives as potential anticancer agents and investigation of their interaction with RecQ helicases
Hanan S. Haggag, Shaimaa M. Aboukhatwa, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107086-107086
Open Access | Times Cited: 4
Development of novel amino-benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors: Design, synthesis, anticancer activity assessment, and pharmacokinetic studies using UPLC-MS/MS
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108335-108335
Closed Access
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Mohamed A. Zeidan, Mahmoud Abdelrahman Alkabbani, Simone Giovannuzzi, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity
Moataz A. Shaldam, Ahmed F. Khalil, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 4
Isocoumarins incorporating chalcone moieties act as isoform selective tumor-associated carbonic anhydrase inhibitors
Mehmet Onyılmaz, Murat Koca, Andrea Ammara, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 13, pp. 1347-1355
Closed Access | Times Cited: 1
Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies
Heba A. Elsebaie, Mohamed S. Nafie, Haytham O. Tawfik, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2553-2569
Closed Access | Times Cited: 1
Sulfonamide-chalcone hybrid compound suppresses cellular adhesion and migration: Experimental and computational insight
Gisele Santos de Araújo, Andréa Felinto Moura, Ayslan B. Barros, et al.
Chemico-Biological Interactions (2024) Vol. 398, pp. 111115-111115
Closed Access | Times Cited: 1
Characterization of GQA as a novel β-lactamase inhibitor of CTX-M-15 and KPC-2 enzymes
Lamiaa A. Al-Madboly, Mohamed Abd El-Salam, Jairo K. Bastos, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR WT , EGFR T790M , and EGFR L858R )
Mahmoud G. Abo Al-Hamd, Haytham O. Tawfik, Omeima Abdullah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
Uncovering the Potential of Chalcone‐Sulfonamide Hybrids: A Systematic Review on Their Anticancer Activity and Mechanisms of Action
Jéssica Maria Teles Souza, Stéphanie Aguiar de Negreiros Matos Silva, Rebeca Barbosa da Rocha, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Open Access
Page 1

Scroll to top